MitoSyne Taurine 1000 — Taurine, 1,000 mg
$27.00 USD

Formula overview
A 100 mg ubiquinol softgel designed around the reduced form of coenzyme Q10, with oil-based delivery and explicit oxidation controls.
| Component | Role | Amount | Specification |
|---|---|---|---|
| Active | Ubiquinol | 100 mg | Reduced coenzyme Q10 (ubiquinol), preferred Kaneka Ubiquinol®; oil suspension |
| Capsule / softgel shell | Opaque or amber softgel | Per unit | Must match final allergen/vegan statement |
| High-oleic sunflower or MCT oil | Processing excipient | q.s.; minimum validated amount | Carrier for oil-soluble ubiquinol |
| Mixed tocopherols | Processing excipient | q.s.; minimum validated amount | Protect carrier oil from oxidation |
| Softgel shell ingredients | Processing excipient | q.s.; minimum validated amount | Gelatin/glycerin/water or validated vegetarian alternative; label accurately |
Active form
Reduced coenzyme Q10 (ubiquinol), preferred Kaneka Ubiquinol®; oil suspension
Reduced-form CoQ10, protected oil suspension, low-oxygen manufacture, source verification and no multi-ingredient cardiovascular blend.
Intended role
Support normal mitochondrial energy metabolism and antioxidant capacity without promising treatment of fatigue, statin effects or cardiovascular disease.
Meta-analyses report improvements in fatigue and selected biomarkers across heterogeneous clinical populations. Evidence in healthy users is less definitive, and results cannot be generalized to every cause of low energy.
Interactions
Can reduce the effect of warfarin and may interact with blood-pressure, glucose-lowering or chemotherapy regimens. Review before surgery or complex medical treatment.
Ubiquinol is the reduced form of coenzyme Q10. The choice supports a clear form-specific product, but it should not be marketed as universally superior for every person.
Ubiquinol is fat soluble, so taking it with a meal containing fat supports absorption.
Many consumers ask this, but medicine use requires individualized review. Do not change statin or anticoagulant therapy without a clinician.
Light and oxygen protection are part of the stability strategy for the active and carrier oil.
The initial softgel shell may use gelatin. A vegetarian shell is possible only after stability, seam and oxygen-barrier validation.